Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 951503

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study.


Glamočlija, Una; Tubić, Biljana; Kondža, Martin; Zolak, Aleksandar; Grubiša, Nataša
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study. // Croatian medical journal, 30 (2018), 59; 124-131 doi:10.3325/cmj.2018.59.124 (domaća recenzija, članak, znanstveni)


CROSBI ID: 951503 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study.

Autori
Glamočlija, Una ; Tubić, Biljana ; Kondža, Martin ; Zolak, Aleksandar ; Grubiša, Nataša

Izvornik
Croatian medical journal (0353-9504) 30 (2018), 59; 124-131

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
pharmacovigilance ; adverse drug reaction ; Bosnia and Herzegovina ; individual case safety report

Sažetak
AIM: To compare individual case safety reports (ICSR) rates and characteristics between Croatia, Serbia, Montenegro, and Bosnia and Herzegovina (B&H). METHODS: This retrospective pharmacoepidemiological study used the data from ICSR received by the Agency for Medicines and Medical Devices in B&H in 2011-2016. The number, characteristics, and sources of reports, suspected drugs, and patient characteristics were analyzed. The results were compared with the publicly available data from Croatia, Serbia, and Montenegro. RESULTS: The number of reported adverse drug reactions per one million of inhabitants was lowest in B&H and highest in Croatia. There were significant differences in reporter characteristics, sources of reports, and the percentage of missing data in ICSR, while the Anatomical Therapeutic Chemical product classes, patient's sex, and adverse drug reaction System Organ Classes were similar. CONCLUSION: Despite the historical and geographical vicinity of B&H and its neighboring countries, there were significant differences in indicators of pharmacovigilance development.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita, Farmacija



POVEZANOST RADA


Profili:

Avatar Url Martin Kondža (autor)

Poveznice na cjeloviti tekst rada:

doi www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Glamočlija, Una; Tubić, Biljana; Kondža, Martin; Zolak, Aleksandar; Grubiša, Nataša
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study. // Croatian medical journal, 30 (2018), 59; 124-131 doi:10.3325/cmj.2018.59.124 (domaća recenzija, članak, znanstveni)
Glamočlija, U., Tubić, B., Kondža, M., Zolak, A. & Grubiša, N. (2018) Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study.. Croatian medical journal, 30 (59), 124-131 doi:10.3325/cmj.2018.59.124.
@article{article, author = {Glamo\v{c}lija, Una and Tubi\'{c}, Biljana and Kond\v{z}a, Martin and Zolak, Aleksandar and Grubi\v{s}a, Nata\v{s}a}, year = {2018}, pages = {124-131}, DOI = {10.3325/cmj.2018.59.124}, keywords = {pharmacovigilance, adverse drug reaction, Bosnia and Herzegovina, individual case safety report}, journal = {Croatian medical journal}, doi = {10.3325/cmj.2018.59.124}, volume = {30}, number = {59}, issn = {0353-9504}, title = {Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study.}, keyword = {pharmacovigilance, adverse drug reaction, Bosnia and Herzegovina, individual case safety report} }
@article{article, author = {Glamo\v{c}lija, Una and Tubi\'{c}, Biljana and Kond\v{z}a, Martin and Zolak, Aleksandar and Grubi\v{s}a, Nata\v{s}a}, year = {2018}, pages = {124-131}, DOI = {10.3325/cmj.2018.59.124}, keywords = {pharmacovigilance, adverse drug reaction, Bosnia and Herzegovina, individual case safety report}, journal = {Croatian medical journal}, doi = {10.3325/cmj.2018.59.124}, volume = {30}, number = {59}, issn = {0353-9504}, title = {Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study.}, keyword = {pharmacovigilance, adverse drug reaction, Bosnia and Herzegovina, individual case safety report} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font